FDA Clears New Lung Drug Jascayd for Progressive Pulmonary Fibrosis
The US FDA approves Jascayd tablets for adults with progressive pulmonary fibrosis (PPF), expanding treatment options. Learn about the drug's impact, study results, and what it means for patients.